{"id":42,"date":"2016-10-28T16:15:04","date_gmt":"2016-10-28T07:15:04","guid":{"rendered":"https:\/\/www.chiken-chubyo.jp\/?page_id=42"},"modified":"2026-04-06T09:43:47","modified_gmt":"2026-04-06T00:43:47","slug":"%e6%b6%88%e5%8c%96%e5%99%a8%e5%86%85%e7%a7%91","status":"publish","type":"page","link":"https:\/\/www.chiken-chubyo.jp\/?page_id=42","title":{"rendered":"\u6d88\u5316\u5668\u5185\u79d1"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/th>\n\u8868\u984c<\/th>\n\u8cac\u4efb\u533b\u5e2b<\/th>\n\u4e0d\u540c
\n\u610f\u66f8<\/th>\n		\u767b\u9332\u671f\u9593<\/th>\n\u7814\u7a76\u671f\u9593<\/th>\n<\/tr>\n
1<\/td>\n\u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u30fb\u518d\u767a\u5927\u8178\u764c\u306b\u5bfe\u3059\u308b\uff12\u6b21\u6cbb\u7642\u3068\u3057\u3066\u306eXELIRI with\/without Bevacizumab \u7642\u6cd5\u3068FOLFIRI with\/without Bevacizumab \u7642\u6cd5\u306e\u56fd\u969b\u5171\u540c\u30e9\u30f3\u30c0\u30e0\u5316\u7b2cIII\u76f8\u6bd4\u8f03\u8a66\u9a13<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u3000<\/td>\n\u00a0<\/td>\n<\/tr>\n
2<\/td>\nJCOG\u30d0\u30a4\u30aa\u30d0\u30f3\u30af\u30d7\u30ed\u30b8\u30a7\u30af\u30c8<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u3000<\/td>\n\u00a0<\/td>\n<\/tr>\n
3<\/td>\n\u5927\u8178\u61a9\u5ba4\u51fa\u8840\u306b\u5bfe\u3059\u308b\u7559\u7f6e\u30b9\u30cd\u30a2\u3092\u7528\u3044\u305f\u5185\u8996\u93e1\u7684\u6b62\u8840\u8853\u306e\u6709\u52b9\u6027\u306e\u7814\u7a76<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u00a0<\/td>\n\u3000<\/td>\n\u00a0<\/td>\n<\/tr>\n
4<\/td>\n\u30d5\u30c3\u5316\u30d4\u30ea\u30df\u30b8\u30f3\u3092\u542b\u3080\u5316\u5b66\u7642\u6cd5\u306b\u4e0d\u5fdc\u306e\u9ad8\u9f62\u8005\u6cbb\u7652\u5207\u9664\u4e0d\u80fd\u9032\u884c\u30fb\u518d\u767a\u5927\u8178\u764c\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c8\u30ea\u30d5\u30eb\u30ea\u30b8\u30f3\u30fb\u30c1\u30d4\u30e9\u30b7\u30eb\u5869\u9178\u5869\u7642\u6cd5\u306e\u7b2c\u2161\u76f8\u81e8\u5e8a\u8a66\u9a13\u3000\uff08T-CORE1401)<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u3000<\/td>\n\u00a0<\/td>\n<\/tr>\n
5<\/td>\n\u300c\u65e9\u671f\u80c3\u764c\u5185\u8996\u93e1\u6cbb\u7652\u5207\u9664\u4f8b\u306b\u304a\u3051\u308b\u7570\u6642\u6027\u591a\u767a\u80c3\u764c\u767a\u751f\u306b\u95a2\u3059\u308b\u7814\u7a76\u300d\uff08JCOG0607\u9644\u968f\u7814\u7a76\uff09<\/td>\n\u5929\u8c9d\u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
6<\/td>\nJCOG1510
\n\u5207\u9664\u4e0d\u80fd\u5c40\u6240\u9032\u884c\u80f8\u90e8\u98df\u9053\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u3068\u5c0e\u5165Docetaxel+CDDP+5-FU\u7642\u6cd5\u5f8c\u306eConversion Surgery\u3092\u6bd4\u8f03\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u7b2cIII\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d\u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
7<\/td>\nJCOG1902
\n\u65e9\u671f\u80c3\u764c\u306b\u5bfe\u3059\u308b\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u306e\u9ad8\u9f62\u8005\u9069\u5fdc\u306b\u95a2\u3059\u308b\u7b2c\u2162\u76f8\u5358\u7fa4\u691c\u8a3c\u7684\u8a66\u9a13<\/td>\n		\u5929\u8c9d\u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
8<\/td>\nJCOG1904
\nClinical-T1bN0M0 \u98df\u9053\u764c\u306b\u5bfe\u3059\u308b\u7dcf\u7dda\u91cf\u4f4e\u6e1b\u3068\u4e88\u9632\u7167\u5c04\u306e\u610f\u7fa9\u3092\u691c\u8a3c\u3059\u308b \u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13<\/td>\n		\u5929\u8c9d\u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2032\u5e74
\n7\u670813\u65e5<\/td>\n<\/tr>\n
\n

9<\/p>\n<\/td>\n

\u5317\u95a2\u6771\u591a\u65bd\u8a2d\u306b\u304a\u3051\u308bHCV\u611f\u67d3\u60a3\u8005\u306e\u73fe\u6cc1\u306b\u3064\u3044\u3066\u306e\u75ab\u5b66\u8abf\u67fb<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

10<\/p>\n<\/td>\n

\u672a\u5206\u5316\u578b\u65e9\u671f\u80c3\u764c\u306b\u5bfe\u3059\u308b\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u306e\u66f4\u306a\u308b\u9069\u5fdc\u62e1\u5927\u306b\u95a2\u3059\u308b\u591a\u6a5f\u95a2\u5171\u540c\u9061\u53ca\u7684\u89b3\u5bdf\u7814\u7a76<\/td>\n\u77f3\u6a4b\u3000\u8087<\/td>\n\u6709<\/a><\/td>\n2025\u5e74
\n12\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

11<\/p>\n<\/td>\n

\u6025\u6027\u81b5\u708e\u306e\u6804\u990a\u958b\u59cb\u6642\u671f\u306e\u691c\u8a0e<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u67081\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

12<\/p>\n<\/td>\n

\u80c6\u9053\u7d30\u80de\u8a3a\u30fb\u751f\u691c\u7d44\u7e54\u8a3a\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u306e\u691c\u8a0e<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

13<\/p>\n<\/td>\n

\u201c\u6b8b\u3055\u308c\u305f\u201dC\u578b\u809d\u708e\u60a3\u8005\u306e\u9662\u5185\u62fe\u3044\u4e0a\u3052<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n6\u670830\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

14<\/p>\n<\/td>\n

JACCRO GC-11\uff08FirSTAR\u8a66\u9a13\uff09
\n\u8853\u5f8c\u88dc\u52a9\u5316\u5b66\u7642\u6cd5\u4e2d\u307e\u305f\u306f\u7d42\u4e86\u5f8c\u65e9\u671f\u306b\u518d\u767a\u3057\u305f\u80c3\u764c\u306b\u5bfe\u3059\u308bCapeOX\uff0b\u30cb\u30dc\u30eb\u30de\u30d6\u7642\u6cd5\u306e\u7b2c\u2161\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2025\u5e74
\n8\u6708<\/td>\n		2027\u5e74
\n8\u6708<\/td>\n<\/tr>\n
\n

15<\/p>\n<\/td>\n

\u6025\u6027\u81b5\u708e\u306e\u6804\u990a\u958b\u59cb\u6642\u671f\u306e\u691c\u8a0e<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u67081\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

16<\/p>\n<\/td>\n

\u30c9\u30af\u30bf\u30fc\u30ba\u30af\u30e9\u30fc\u30af\u306b\u3088\u308b\u5916\u6765\u8a3a\u7642\u306e\u5909\u5316<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

17<\/p>\n<\/td>\n

\u80c3\u306e\u6709\u830e\u6027\u30dd\u30ea\u30fc\u30d7\u51fa\u8840\u306b\u5bfe\u3057\u3066\u7559\u7f6e\u30b9\u30cd\u30a2\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u75c7\u4f8b<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u67081\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

18<\/p>\n<\/td>\n

T-CORE 2201
\n\u9032\u884c\u81b5\u764c\u306b\u5bfe\u3059\u308bGEM\/nabPTX\u7642\u6cd5\u3068\u30ec\u30dc\u30d5\u30ed\u30ad\u30b5\u30b7\u30f3\u306e\u4f75\u7528\u52b9\u679c\u306b\u95a2\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u524d\u5411\u304d\u7b2c\u2161\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2026\u5e74
\n12\u670831\u65e5<\/td>\n		2028\u5e74
\n12\u670831\u65e5<\/td>\n<\/tr>\n
\n

19<\/p>\n<\/td>\n

\u81ea\u5df1\u514d\u75ab\u6027\u809d\u708e\u60a3\u8005\u30ec\u30b8\u30b9\u30c8\u30ea\u306e\u69cb\u7bc9<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2026\u5e74
\n6\u670830\u65e5<\/td>\n<\/tr>\n
\n

20<\/p>\n<\/td>\n

\u6d88\u5316\u5668\u5185\u8996\u93e1\u306b\u95a2\u9023\u3059\u308b\u75be\u60a3\u3001\u6cbb\u7642\u624b\u6280\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u69cb\u7bc9<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n2028\u5e74
\n12\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

21<\/p>\n<\/td>\n

PRABITAS
\n\u5207\u9664\u4e0d\u80fd\u5927\u8178\u764c\u306b\u5bfe\u3059\u308b\u30c8\u30ea\u30d5\u30eb\u30ea\u30b8\u30f3\u30fb\u30c1\u30d4\u30e9\u30b7\u30eb\uff0b\u30d9\u30d0\u30b7\u30ba\u30de\u30d6\u306e\u5f93\u6765\u6cd5\u3068\u9694\u9031\u6cd5\u306e\u5b9f\u7528\u7684\u30e9\u30f3\u30c0\u30e0\u5316\u7b2c\u2162\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

22<\/p>\n<\/td>\n

10mm\u4ee5\u4e0b\u306e\u65e9\u671f\u5927\u8178\u764c\u3068\u9ad8\u7570\u578b\u5ea6\u817a\u816b\u306e\u5185\u8996\u93e1\u7684\u6cbb\u7642\u72b6\u6cc1<\/td>\n\u5c71\u5ca1 \u6b63\u6cbb<\/td>\n\u6709<\/a><\/td>\n2028\u5e74
\n12\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

23<\/p>\n<\/td>\n

\u6d88\u5316\u7ba1\u7570\u7269\u306b\u304a\u3051\u308b\u5185\u8996\u93e1\u7684\u7570\u7269\u9664\u53bb\u8853\u306e\u6709\u52b9\u6027\u306e\u691c\u8a0e<\/td>\n\u702c\u5c71 \u4f91\u4eae<\/td>\n\u6709<\/a><\/td>\n2029\u5e74
\n3\u67086\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

24<\/p>\n<\/td>\n

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)\u306b\u5bfe\u3059\u308b\u5b9f\u614b\u8abf\u67fb<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2027\u5e74
\n3\u670831\u65e5<\/td>\n<\/tr>\n
\n

25<\/p>\n<\/td>\n

\u81e8\u5e8a\u75c5\u671fI\u671f\u98df\u9053\u764c\u3092\u5bfe\u8c61\u3068\u3057\u305f\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u7d71\u5408\u89e3\u6790\u306b\u95a2\u3059\u308b\u7814\u7a76<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

26<\/p>\n<\/td>\n

\u98df\u9053\u764c\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u5f8c\u72ed\u7a84\u306b\u5bfe\u3059\u308bEBD\u5358\u72ec\u7642\u6cd5\u304a\u3088\u3073\u30b9\u30c6\u30ed\u30a4\u30c9\u5c40\u6ce8\u4f75\u7528EBD\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2c III \u76f8\u8a66\u9a13<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

27<\/p>\n<\/td>\n

\u591a\u767a\u6027\u809d\u56a2\u80de\u75c7\u306e\u5168\u56fd\u75ab\u5b66\u8abf\u67fb<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n2026\u5e74
\n3\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

28<\/p>\n<\/td>\n

\u5207\u9664\u4e0d\u80fd\u80c6\u9053\u764c\u306b\u5bfe\u3059\u308b\u30c7\u30e5\u30eb\u30d0\u30eb\u30de\u30d6\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2027\u5e74
\n3\u67081\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

29<\/p>\n<\/td>\n

\u80c6\u7ba1\u6df1\u90e8\u633f\u7ba1\u6642\u306e\u30d7\u30ec\u30ab\u30c3\u30c8\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027<\/td>\n\u5927\u95a2 \u745e\u6cbb<\/td>\n\u6709<\/a><\/td>\n2029\u5e74
\n4\u67081\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

30<\/p>\n<\/td>\n

\u6025\u6027\u809d\u708e\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5bfe\u8c61\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n2028\u5e74
\n3\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

31<\/p>\n<\/td>\n

\u770b\u8b77\u5e2b\u3068\u533b\u5e2b\u3067\u884c\u3063\u305fERCP\u30d1\u30b9\u306e\u30d0\u30ea\u30a2\u30f3\u30b9\u5206\u6790\u3068\u6539\u8a02(\u6297\u751f\u5264\u9069\u6b63\u4f7f\u7528\u306b\u95a2\u3059\u308b\u691c\u8a0e)<\/td>\n\u5c71\u5ca1 \u6b63\u6cbb<\/td>\n\u6709<\/a><\/td>\n2028\u5e74
\n12\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

32<\/p>\n<\/td>\n

\u4e0a\u90e8\u6d88\u5316\u7ba1\u5185\u8996\u93e1\u691c\u67fb\u306b\u304a\u3051\u308b\u30b9\u30b3\u30fc\u30d7\u753b\u8cea\u3068\u75c5\u5909\u691c\u51fa\u7387\u306e\u691c\u8a0e<\/td>\n\u702c\u5c71 \u4f91\u4eae<\/td>\n\u6709<\/a><\/td>\n2029\u5e74
\n7\u670812\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

33<\/p>\n<\/td>\n

D-CURE trial
\n20\u339c\u4ee5\u4e0b\u306e\u975e\u4e73\u982d\u90e8\u5341\u4e8c\u6307\u8178\u4e0a\u76ae\u6027\u816b\u760d\u306b\u5bfe\u3059\u308b\u5f93\u6765\u6cd5EMR\u3068\u6d78\u6c34\u4e0bEMR\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13<\/td>\n		\u77f3\u6a4b\u3000\u8087<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

34<\/p>\n<\/td>\n

JACCRO GC-12\uff08C-SOLVE \u8a66\u9a13\uff09
\nHER2 \u9670\u6027\u30fbCLDN18.2 \u967d\u6027\u306e\u5207\u9664\u4e0d\u80fd\u9032\u884c\u518d\u767a\u80c3\u307e\u305f\u306f\u98df\u9053\u80c3\u63a5\u5408\u90e8\u764c\u306b\u5bfe\u3059\u308bCapeOX\uff0b\u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6\u7642\u6cd5\u3092\u53c2\u7167\u7fa4\u3068\u3059\u308bSOX\uff0b\u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3092\u691c\u8a0e\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u975e\u6bd4\u8f03\u7b2c\u2161\u76f8\u81e8\u5e8a\u8a66\u9a13<\/td>\n		\u5929\u8c9d\u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2026\u5e74
\n11\u670825\u65e5<\/td>\n		2029<\/span>\u5e74
\n11\u670825\u65e5<\/td>\n<\/tr>\n
\n

35<\/p>\n<\/td>\n

JCOG2315
\n\u5e83\u7bc4\u306a\u98df\u9053\u8868\u5728\u764c\u306b\u5bfe\u3059\u308b\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u5f8c\u306e\u72ed\u7a84\u4e88\u9632\u3092\u76ee\u7684\u3068\u3059\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u5c40\u6ce8\uff0b\u5185\u670d\u4f75\u7528\u7642\u6cd5\u304a\u3088\u3073\u30b9\u30c6\u30ed\u30a4\u30c9\u5c40\u6ce8\u5358\u72ec\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2cIII\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2031\u5e74
\n6\u670810\u65e5<\/td>\n<\/tr>\n
\n

36<\/p>\n<\/td>\n

GENTLE-Z\u8a66\u9a13
\nCLDN18.2\u967d\u6027\u306e\u6cbb\u7652\u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u30fb\u518d\u767a\u306e\u80c3\/\u98df\u9053\u80c3\u63a5\u5408\u90e8\/\u98df\u9053\u817a\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6+\u5316\u5b66\u7642\u6cd5\u306e\u521d\u56de\u6295\u4e0e\u91cf\u8abf\u7bc0\u306b\u3088\u308b\u5b89\u5168\u6027\u53ca\u3073\u6709\u52b9\u6027\u3092\u8a55\u4fa1\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u7b2cII\u76f8\u81e8\u5e8a\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2026\u5e74
\n3\u6708<\/td>\n		2028\u5e74
\n3\u6708<\/td>\n<\/tr>\n
\n

37<\/p>\n<\/td>\n

\u80c6\u7ba1\u30d7\u30e9\u30b9\u30c1\u30c3\u30af\u30b9\u30c6\u30f3\u30c8\u7559\u7f6e\u4e2d\u306b\u80c6\u9053\u51fa\u8840\u306b\u3088\u308b\u9589\u585e\u6027\u80c6\u7ba1\u708e\u3092\u767a\u75c7\u3057\u305f\u81b5\u764c\u306e1\u4f8b<\/td>\n\u702c\u5c71 \u4f91\u4eae<\/td>\n\u6709<\/a><\/td>\n2030\u5e74
\n1\u67086\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

38<\/p>\n<\/td>\n

KHBO-2201-YOTSUBA
\n\u5207\u9664\u4e0d\u80fd\u307e\u305f\u306f\u518d\u767a\u80c6\u9053\u764c\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\/S-1\uff08GCS\uff09\u7642\u6cd5\u3068\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\/\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2cIII\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2029\u5e74
\n9\u670830\u65e5<\/td>\n<\/tr>\n
\n

39<\/p>\n<\/td>\n

JACCRO GC-12AR
\n\u300cHER2\u9670\u6027\u30fbCLDN18.2\u967d\u6027\u306e\u5207\u9664\u4e0d\u80fd\u9032\u884c\u518d\u767a\u80c3\u307e\u305f\u306f\u98df\u9053\u80c3\u63a5\u5408\u90e8\u764c\u306b\u5bfe\u3059\u308bCapeOX\uff0b\u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6\u7642\u6cd5\u3092\u53c2\u7167\u7fa4\u3068\u3059\u308bSOX\uff0b\u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3092\u691c\u8a0e\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u975e\u6bd4\u8f03\u7b2c\u2161\u76f8\u81e8\u5e8a\u8a66\u9a13\uff08JACCRO GC-12\uff08C-SOLVE\u8a66\u9a13\uff09\uff09\u300d\u306b\u304a\u3051\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u7814\u7a76<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

40<\/p>\n<\/td>\n

irAE\u809d\u969c\u5bb3\u306b\u304a\u3051\u308b\u30bb\u30eb\u30bb\u30d7\u30c8\u6295\u4e0e\u306e\u5b9f\u614b\u8abf\u67fb<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n2026\u5e74
\n12\u670831\u65e5<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\n

41<\/p>\n<\/td>\n

\u80c3\u764c\u7d44\u7e54\u306e\u8907\u96d1\u6027\u3068\u514d\u75ab\u6cbb\u7642\u52b9\u679c\u306e\u53cd\u5fdc\u3092\u89e3\u660e\u3059\u308b\u305f\u3081\u306e\u5305\u62ec\u7684\u306a\u7a7a\u9593\u30d7\u30ed\u30c6\u30aa\u30df\u30af\u30b9\u30a2\u30c8\u30e9\u30b9<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2030\u5e74
\n1\u67089\u65e5<\/td>\n<\/tr>\n
\n

42<\/p>\n<\/td>\n

T-CORE 2401
\nRAS\/BRAF\u91ce\u751f\u578b\u5207\u9664\u4e0d\u80fd\u53f3\u5074\u7d50\u8178\u764c\u306b\u5bfe\u3059\u308b\u4e00\u6b21\u6cbb\u7642\u3068\u3057\u3066\u306emFOLFOX6 + Cetuximab (q2w) \u7642\u6cd5\u3068mFOLFOX6 + Bevacizumab\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u3092\u6bd4\u8f03\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u524d\u5411\u304d\u7b2c\u2161\u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2027\u5e74
\n6\u670830\u65e5<\/td>\n		2029\u5e74
\n6\u670830\u65e5<\/td>\n<\/tr>\n
\n

43<\/p>\n<\/td>\n

KHBO2201-YOTSUBA-BM
\n\u5207\u9664\u4e0d\u80fd\u307e\u305f\u306f\u518d\u767a\u80c6\u9053\u764c\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\/S-1\uff08GCS\uff09\u7642\u6cd5\u3068\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\/\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\/\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2cIII\u76f8\u8a66\u9a13\u306b\u4ed8\u968f\u3059\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u63a2\u7d22\u7814\u7a76<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2029\u5e74
\n9\u670830\u65e5<\/td>\n<\/tr>\n
\n

44<\/p>\n<\/td>\n

\u8840\u5c0f\u677f\u6e1b\u5c11\u3092\u4f34\u3046\u6162\u6027\u809d\u75be\u60a3\u75c7\u4f8b\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30a2\u30d0\u30c8\u30ed\u30f3\u30dc\u30d1\u30b0\u306e\u6709\u52b9\u6027\u53ca\u3073\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2025\u5e74
\n10\u670831\u65e5<\/td>\n<\/tr>\n
\n

45<\/p>\n<\/td>\n

JCOG2215\u3000
\n\u98df\u9053\u764c\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u5f8c\u72ed\u7a84\u306b\u5bfe\u3059\u308b EBD \u5358\u72ec\u7642\u6cd5\u304a\u3088\u3073 \u30b9\u30c6\u30ed\u30a4\u30c9\u5c40\u6ce8\u4f75\u7528 EBD \u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2c III \u76f8\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2029\u5e74
\n2\u670818\u65e5<\/td>\n<\/tr>\n
\n

46<\/p>\n<\/td>\n

JCOG1109A1
\n\u5c40\u6240\u9032\u884c\u98df\u9053\u764c\u306b\u304a\u3051\u308b\u8853\u524d\u6cbb\u7642\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306b\u95a2\u3059\u308b\u63a2\u7d22\u7684\u7814\u7a76\u5b9f\u65bd\u8a08\u753b\u66f8ver. 1.0.1
\nJCOG1109\u300c\u81e8\u5e8a\u75c5\u671fIB\/II\/III\u98df\u9053\u764c\uff08T4\u3092\u9664\u304f\uff09\u306b\u5bfe\u3059\u308b\u8853\u524dCF\u7642\u6cd5\/\u8853\u524dDCF\u7642\u6cd5\/\u8853\u524dCF-RT\u7642\u6cd5\u306e\u7b2cIII\u76f8\u6bd4\u8f03\u8a66\u9a13\u300d\u306e\u9644\u968f\u7814\u7a76<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2026\u5e74
\n12\u6708<\/td>\n<\/tr>\n
\n

47<\/p>\n<\/td>\n

VEGA trial
\n\u8840\u6db2\u5faa\u74b0\u816b\u760dDNA\u9670\u6027\u306e\u9ad8\u30ea\u30b9\u30afStageII\u53ca\u3073\u4f4e\u30ea\u30b9\u30afStageIII\u7d50\u8178\u764c\u6cbb\u7652\u5207\u9664\u4f8b\u306b\u5bfe\u3059\u308b\u8853\u5f8c\u88dc\u52a9\u5316\u5b66\u7642\u6cd5\u3068\u3057\u3066\u306eCAPOX\u7642\u6cd5\u3068\u624b\u8853\u5358\u72ec\u3092\u6bd4\u8f03\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u7b2cIII\u76f8\u6bd4\u8f03\u8a66\u9a13<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2031\u5e74
\n3\u6708<\/td>\n<\/tr>\n
\n

48<\/p>\n<\/td>\n

DPC\u30c7\u30fc\u30bf\u306b\u3088\u308b\u5927\u8178EMR\u75c7\u4f8b\u306e\u5206\u6790\u3068\u5927\u8178EMR\u30d1\u30b9\u4f5c\u6210\u524d\u5f8c\u306e\u6bd4\u8f03<\/td>\n\u5c71\u5ca1 \u6b63\u6cbb<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2029\u5e74
\n12\u670831\u65e5<\/td>\n<\/tr>\n
\n

49<\/p>\n<\/td>\n

2014\u5e74\u301c2024\u5e74\u5916\u6765\u53d7\u8a3a\u8005\u306eHCV\u611f\u67d3\u72b6\u6cc1<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\u00a0<\/td>\n2030\u5e74
\n7\u670831\u65e5<\/td>\n<\/tr>\n
\n

50<\/p>\n<\/td>\n

T-CORE 2401\u4ed8\u968f\u7814\u7a76
\nT-CORE 2401\uff1aRAS\/BRAF\u91ce\u751f\u578b\u5207\u9664\u4e0d\u80fd\u53f3\u5074\u7d50\u8178\u764c\u306b\u5bfe\u3059\u308b\u4e00\u6b21\u6cbb\u7642\u3068\u3057\u3066\u306emFOLFOX6 + Cetuximab (q2w) \u7642\u6cd5\u3068mFOLFOX6 + Bevacizumab\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u3092\u6bd4\u8f03\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u524d\u5411\u304d\u7b2c\u2161\u76f8\u8a66\u9a13\u300d\u306b\u4ed8\u968f\u3059\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u7814\u7a76\u3000<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u00a0<\/td>\n2027\u5e74
\n6\u6708<\/td>\n		2029\u5e74
\n6\u6708<\/td>\n<\/tr>\n
\n

51<\/p>\n<\/td>\n

C\u578b\u975e\u4ee3\u511f\u6027\u809d\u786c\u5909\u306b\u5bfe\u3059\u308b\u30bd\u30db\u30b9\u30d6\u30d3\u30eb\/\u30d9\u30eb\u30d1\u30bf\u30b9\u30d3\u30eb\u6cbb\u7642\u306e\u9577\u671f\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u5317\u95a2\u6771\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2026\u5e74
\n12\u670831\u65e5<\/td>\n<\/tr>\n
\n

52<\/p>\n<\/td>\n

\u809d\u7d30\u80de\u764c\u5168\u8eab\u85ac\u7269\u7642\u6cd5\u306b\u304a\u3051\u308b\u809d\u4e0d\u5168\u5408\u4f75\u75c7\u306e\u73fe\u72b6\u8abf\u67fb<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2030<\/span>\u5e74
\n7<\/span>\u670831<\/span>\u65e5<\/td>\n<\/tr>\n
\n

53<\/p>\n<\/td>\n

\u5185\u8996\u93e1\u5207\u9664\u3055\u308c\u305fpT1<\/span>\u5927\u8178\u764c\u3092\u6709\u3059\u308b\u9ad8\u9f62\u8005\u306b\u5bfe\u3059\u308b\u8ffd\u52a0\u8178\u5207\u9664\u5f8c\u306e\u6cbb\u7642\u6210\u7e3e\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5f8c\u308d\u5411\u304d\u7814\u7a76<\/td>\n\u77f3\u6a4b \u8087<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2028\u5e74
\n3\u670831\u65e5<\/span><\/td>\n<\/tr>\n
\n

54<\/p>\n<\/td>\n

\u30cb\u30dc\u30eb\u30de\u30d6\u7642\u6cd5\u3067\u9577\u671f\u75c5\u52e2\u5236\u5fa1\u304c\u3067\u304d\u305f\u80c3\u60aa\u6027\u9ed2\u8272\u816b\u306e1<\/span>\u4f8b<\/td>\n\u702c\u5c71\u00a0<\/span>\u4f91\u4eae<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2031\u5e74
\n1\u670815\u65e5<\/span><\/td>\n<\/tr>\n
\n

55<\/p>\n<\/td>\n

JCOG1109A2
\nJCOG1109\u300c\u81e8\u5e8a\u75c5\u671fIB\/II\/III\u98df\u9053\u764c\uff08T4\u3092\u9664\u304f\uff09\u306b\u5bfe\u3059\u308b\u8853\u524dCF\u7642\u6cd5\/\u8853\u524dDCF\u7642\u6cd5\/\u8853\u524dCF-RT\u7642\u6cd5\u306e\u7b2cIII\u76f8\u6bd4\u8f03\u8a66\u9a13\u300d\u306e\u9644\u968f\u7814\u7a76
\n\u81e8\u5e8a\u75c5\u671fIB\/II\/III\u98df\u9053\u764c\uff08T4\u3092\u9664\u304f\uff09\u306e\u8853\u524d\u6cbb\u7642\u5f8c\u306e\u624b\u8853\u4f8b\u3092\u5bfe\u8c61\u3068\u3057\u305f\u6cbb\u7642\u52b9\u679c\u304a\u3088\u3073\u4e88\u5f8c\u4e88\u6e2c\u306b\u95a2\u3059\u308b\u89e3\u6790\u7814\u7a76<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2029\u5e74
\n3\u670831\u65e5<\/span><\/td>\n<\/tr>\n
\n

56<\/p>\n<\/td>\n

JCOG1217A1
\nJCOG1217\u300c\u65e9\u671f\u98df\u9053\u764c\u306b\u5bfe\u3059\u308b\u5185\u8996\u93e1\u7684\u7c98\u819c\u4e0b\u5c64\u5265\u96e2\u8853\u5f8c\u306e\u72ed\u7a84\u4e88\u9632\u3092\u76ee\u7684\u3068\u3059\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u5185\u670d\u7642\u6cd5\u304a\u3088\u3073\u30b9\u30c6\u30ed\u30a4\u30c9\u5c40\u6ce8\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u7b2cIII\u76f8\u8a66\u9a13\u300d\u306e\u9644\u968f\u7814\u7a76<\/td>\n		\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2028\u5e74
\n3\u67081\u65e5<\/span><\/td>\n<\/tr>\n
\n

57<\/p>\n<\/td>\n

\u809d\u7d30\u80de\u764c\u85ac\u7269\u6cbb\u7642\u306e\u30a2\u30a6\u30c8\u30ab\u30e0<\/td>\n\u8352\u6728 \u771e\u88d5<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2031\u5e74
\n2\u670826\u65e5<\/span><\/td>\n<\/tr>\n
\n

58<\/p>\n<\/td>\n

\u30d4\u30ed\u30ea\u83cc\u9664\u83cc\u5916\u6765\u306e\u73fe\u72b6<\/td>\n\u5929\u8c9d \u8ce2\u4e8c<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2026\u5e74
\n3\u670831\u65e5<\/span><\/td>\n<\/tr>\n
\n

59<\/p>\n<\/td>\n

\u91cd\u8907\u764c\u3067\u306e\u809d\u816b\u760d\u306e\u7d44\u7e54\u578b\u89e3\u6790<\/td>\n\u85e4\u539f \u7f8e\u7434<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2031\u5e74
\n3\u670831\u65e5<\/span><\/td>\n<\/tr>\n
\n

60<\/p>\n<\/td>\n

\u653e\u5c04\u7dda\u6027\u8178\u708e\u306b\u5bfe\u3059\u308b\u5f53\u9662\u3067\u306e\u6cbb\u7642\u72b6\u6cc1<\/td>\n\u5c71\u5ca1 \u6b63\u6cbb<\/td>\n\u6709<\/a><\/td>\n\n

 <\/p>\n<\/td>\n

2030\u5e74
\n12\u670831\u65e5<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 \u8868\u984c \u8cac\u4efb\u533b\u5e2b \u4e0d\u540c \u610f\u66f8 \u767b\u9332\u671f\u9593 \u7814\u7a76\u671f\u9593 1 \u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u30fb\u518d\u767a\u5927\u8178\u764c\u306b\u5bfe\u3059\u308b\uff12\u6b21\u6cbb\u7642\u3068\u3057\u3066\u306eXELIRI with\/without Bevacizumab \u7642\u6cd5\u3068FOLFIRI with\/without B […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":9,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-42","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/pages\/42","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42"}],"version-history":[{"count":191,"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/pages\/42\/revisions"}],"predecessor-version":[{"id":3765,"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/pages\/42\/revisions\/3765"}],"up":[{"embeddable":true,"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=\/wp\/v2\/pages\/9"}],"wp:attachment":[{"href":"https:\/\/www.chiken-chubyo.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}